This content is from: Canada

UPDATE-Tax Court of Canada rejects Glaxo Canada transfer pricing appeal

GlaxoSmithKline has lost an appeal in the Tax Court of Canada over a reassessment of its tax liability on supplier transactions in the early 1990s

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | 30 Day Trial